Russell Vance

Russell Vance

Title
Professor
Department
Dept of Molecular & Cell Biology
Phone
(510) 643-2795
Research Expertise and Interest
immunology, microbiology, infectious disease, molecular and cell biology
Research Description

The Vance Laab is interested in all aspects of the complex interrelationship between pathogens and their hosts. In particular, they apply the modern tools of biology and genetics to answer a variety of questions at a molecular level: how is the presence of pathogenic bacteria sensed by hosts? Are pathogenic bacteria distinguished from harmless bacteria, and if so, how? What innate immune mechanisms protect cells from pathogens? How do cells coordinate defenses that are appropriate for various categories of pathogens? What mechanisms have pathogens evolved to evade host defenses?

In the News

October 1, 2018

UC Berkeley research led to Nobel Prize-winning immunotherapy

Immunologist James P. Allison today shared the 2018 Nobel Prize in Physiology or Medicine for groundbreaking work he conducted on cancer immunotherapy at UC Berkeley during his 20 years as director of the campus’s Cancer Research Laboratory.
January 19, 2017

The yin-yang of cancer and infectious disease

Doctors have had great success using vaccines to boost the immune system to fight infectious diseases like smallpox and measles, but only recently have immune system boosters been tried against cancer.
May 9, 2013

Howard Hughes Medical Institute names three new campus investigators

Nicole King, Russell Vance and Michael Rape took different routes to UC Berkeley’s Department of Molecular and Cell Biology, but they’ve ended up with one of the mostly highly sought positions at any American university: a fully subsidized appointment, with added research funds, as a Howard Hughes Medical Institute (HHMI) investigator.

In the News

October 1, 2018

UC Berkeley research led to Nobel Prize-winning immunotherapy

Immunologist James P. Allison today shared the 2018 Nobel Prize in Physiology or Medicine for groundbreaking work he conducted on cancer immunotherapy at UC Berkeley during his 20 years as director of the campus’s Cancer Research Laboratory.
January 19, 2017

The yin-yang of cancer and infectious disease

Doctors have had great success using vaccines to boost the immune system to fight infectious diseases like smallpox and measles, but only recently have immune system boosters been tried against cancer.
May 9, 2013

Howard Hughes Medical Institute names three new campus investigators

Nicole King, Russell Vance and Michael Rape took different routes to UC Berkeley’s Department of Molecular and Cell Biology, but they’ve ended up with one of the mostly highly sought positions at any American university: a fully subsidized appointment, with added research funds, as a Howard Hughes Medical Institute (HHMI) investigator.

Loading Class list ...
.